Vaccitech to Present Positive Final Data at EASL Congress for Phase 1b/2 HBV002 Study in Adults with Chronic Hepatitis B
June 21, 2023 09:03 ET
|
Vaccitech plc
Meaningful, durable reductions of HBsAg were seen, both in participants who received VTP-300 alone and in combination with a low-dose PD-1 inhibitorTwo patients developed a non-detectable HBsAg level,...
OpGen Presents Unyvero Urinary Tract Infection Panel Trial Results at ASM Microbe 2023 Conference
June 20, 2023 07:30 ET
|
OpGen, Inc.
‘Multi-Center Clinical Trial Using a Novel Semi-Quantitative Multiplex-PCR Based Diagnostic Panel for Urinary Tract Specimens’ presented on June 17th, 2023Presentation focused on primary study...
Global Infectious Disease Testing Market Size To Grow USD 43.3 Billion By 2032 | CAGR of 5.9%
June 13, 2023 07:30 ET
|
SPHERICAL INSIGHTS LLP
New York, United States , June 13, 2023 (GLOBE NEWSWIRE) -- The Global Infectious Disease Testing Market Size is to grow from USD 24.2 Billion in 2022 to USD 43.3 billion by 2032, at a Compound...
Vir Biotechnology Announces Multiple Abstracts Highlighting New Hepatitis B and D Data Accepted for Presentation at EASL™ Congress 2023
June 07, 2023 02:13 ET
|
Vir Biotechnology, Inc.
SAN FRANCISCO, June 07, 2023 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that five abstracts highlighting new data from the Company’s broad hepatitis portfolio...
Primary.Health and Poppy Launch A New Air Safety Program for Schools Across the United States
May 31, 2023 12:35 ET
|
Primary.Health
SAN FRANCISCO, May 31, 2023 (GLOBE NEWSWIRE) -- Primary.Health, a web-based platform to manage infectious disease testing and tracking programs, and Poppy, providers of the world’s most advanced Air...
OpGen Reports First Quarter 2023 Financial Results and Provides Business Update
May 15, 2023 16:15 ET
|
OpGen, Inc.
Total revenue for the first quarter of 2023 was approximately $0.91 million, an increase of approximately 94% compared to the first quarter of 2022Expanded U.S. growth opportunities with the Unyvero...
OpGen to Provide Business Update and Financial Results for the First Quarter 2023 on May 15th at 4:30 p.m. Eastern Time
May 08, 2023 07:30 ET
|
OpGen, Inc.
ROCKVILLE, Md., May 08, 2023 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN) (“OpGen” or “the Company”) announced today that the Company will provide a business update and report its first quarter...
OpGen’s Subsidiary Curetis Meets All Remaining Key Milestones in R&D Collaboration with FIND
April 26, 2023 16:30 ET
|
OpGen, Inc.
Triggers milestone payment of approximately $0.3 million ROCKVILLE, Md., April 26, 2023 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “the Company”), a precision medicine company...
Monoclonal Antibody Therapeutics Market to Surpass US$ 534.26 Billion by 2030, Says Coherent Market Insights (CMI)
April 12, 2023 08:40 ET
|
CMI
Burlingame, April 12, 2023 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, Global Monoclonal Antibody Therapeutics Market is estimated to be valued at US$ 205.39 Billion in 2023 and is...
Veru Announces Preclinical Study Results that Demonstrate Sabizabulin Inhibits Poxviruses
April 11, 2023 08:30 ET
|
Veru Inc.
Sabizabulin inhibited the cell release and cell-to-cell spread of poxvirus in a preclinical study Veru further expands study of sabizabulin for the treatment of poxvirus acute respiratory distress...